Blocklisting Return

RNS Number : 6564V
Oxford Biomedica PLC
30 May 2008
 



For Immediate Release

30 May 2008



SCHEDULE 5

BLOCKLISTING SIX MONTHLY RETURN


To:    Listing Applications

UK Listing Authority

Financial Services Authority

25, The North Colonnade

Canary Wharf

LondonE14 5HS


1. Name of company          OXFORD BIOMEDICA PLC


2. Name of scheme            SHARE OPTION SCHEME


3. Period of return:    From : 17 November 2007 To : 30 May 2008


4. Number and class of share(s) (amount of stock / debt security) not issued under scheme at start of period:    

4,487,664 ORDINARY SHARES OF 1p EACH


5. Number of shares issued / allotted under scheme during period:

264,100 ORDINARY SHARES OF 1p EACH 


6. Balance under scheme not yet issued / allotted at end of period:

4,223,564 ORDINARY SHARES OF 1p EACH


7. Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission:

17,383,143 ORDINARY SHARES OF 1p EACH:

DATE ADMITTED 9 May 2001 


Please confirm total number of shares in issue at the end of the period in order for us to update our records:

537,289,761 ORDINARY SHARES OF 1p EACH 


Contact for queries

Name    ANDREW WOOD


Address OXFORD BIOMEDICA PLC, MEDAWAR CENTRE, 

             OXFORD SCIENCE PARKOXFORD OX4 4GA


Telephone 01865 783000


Person making the return

Name    ANDREW WOOD


Position COMPANY SECRETARY


Signature        ……………………………………………….


The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLREALSEDAFPEFE
UK 100

Latest directors dealings